Respiratory tract immune response to microbial pathogens.
Effective resistance to respiratory tract infection depends principally on specific immunity on mucosal surfaces of the upper or lower respiratory tract. Respiratory tract immune response comprises antibody and cell-mediated systems and may be induced most readily by surface presentation of replicating agents but can result from parenteral or local presentation of highly immunogenic antigens. Upper and lower respiratory tract systems differ in immunologic competence, with the lungs having a greater inventory of protective mechanisms than the trachea or nose. Several effective vaccines have been developed for prevention or modification of respiratory tract diseases.
D000818:Animals; D000831:Animals, Newborn; D001424:Bacterial Infections / Q000150:complications / Q000276:immunology* / Q000662:veterinary*; D001885:Bordetella Infections / Q000276:immunology / Q000517:prevention & control / Q000662:veterinary*; D002415:Cats; D002417:Cattle; D004285:Dogs; D007242:Herpesvirus 1, Bovine / Q000276:immunology; D006736:Horses; D007111:Immunity, Cellular; D007070:Immunoglobulin A / Q000096:biosynthesis; D007074:Immunoglobulin G / Q000096:biosynthesis; D008168:Lung / Q000276:immunology / Q000378:metabolism; D009297:Nasal Mucosa / Q000276:immunology / Q000378:metabolism; D012766:Pasteurellosis, Pneumonic / Q000209:etiology / Q000276:immunology / Q000517:prevention & control; D010587:Phagocytosis; D010850:Picornaviridae Infections / Q000276:immunology / Q000517:prevention & control / Q000662:veterinary*; D012141:Respiratory Tract Infections / Q000209:etiology / Q000276:immunology* / Q000662:veterinary*; D012756:Sheep; D013552:Swine; D014611:Vaccination / Q000662:veterinary
D007070:Immunoglobulin A; D007074:Immunoglobulin G